Replies to post #10221 on Arch Therapeutics Inc (ARTH)

[Polyphemus]

Reading between the PR lines: (1) 2.5 years after FDA 510(k), TN & crew have started to think about reimbursement. (2) A pilot clinical trial generated MD enthusiasm. The why no sales?
Distressed to see balance sheet shows no saleable inventory on hand, only WIP. Quo vadis?